Scientific Director US Medical Affairs, Pulmonary Hypertension

About us

Based in Parma, Italy, Chiesi is an international research-focused pharmaceuticals and healthcare group with over 85 years’ experience, operating in 30 countries with more than 6,000 employees (Chiesi Group). To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, the Group research, develops and markets innovative drugs in its three therapeutic areas: AIR (products and services that promote respiration, from new-born to adult populations), RARE (treatment for patients with rare and ultra-rare diseases) and CARE (products and services that support special care and consumer-facing self-care).
We are proud to be the largest global pharmaceutical group to be awarded B Corp Certification, a recognition of high social and environmental standards. We are a reliable company that adopts and promotes transparent ethical behavior at all levels. 
We are committed to embrace diversity, inclusion and equal opportunities. In fact, we are a global family made up of different cultures, different genders, generations, ethnicities, abilities, sexual identities and many other enriching diversities. 

 

Chiesi USA

Chiesi USA is a specialty pharmaceutical company focused on developing and promoting products for the hospital, adjacent specialty and rare disease markets. We are a B Corp™ and Benefit company awarded Top Employer status for six consecutive years and certified as a Great Place to Work. 
At Chiesi, we share an entrepreneurial spirit and act as a force for good, pursuing high social and environmental standards, to ensure the wellbeing of our people, patients, and communities. We offer a work environment where professionals have the opportunity to build a purposeful career focused on helping others while achieving a fulfilling work-life balance, meeting exciting challenges, and engaging in important and rewarding work.

 

What we offer

Chiesi offers competitive benefits, services, and programs that enrich the personal and professional lives of our employees.   Our shared values of passion, innovation, trust and integrity bring out the individual talents and diverse perspectives of each of our colleagues.  Our environment encourages each individual to reach his or her full potential and drive outstanding results. We celebrate that “Every one of us is different. Every one of us is Chiesi."

 

Who we are looking for

Purpose

The primary responsibility of this role is to lead the development, execution, and implementation of the global Medical Affairs strategy for Seralutinib within the US market in partnership with Gossamer Bio, our Alliance Partner. This includes internal and external engagement, generation of clinical and scientific data, pre-launch activities, publication planning and oversight of educational initiatives. Additionally, this role involves a key partnership and co-creation with the ex-US (ROW) Medical Affairs Head for Seralutinib to shape and align the global medical affairs strategy. The individual is accountable for building the bridge between global strategic considerations and ROW input, ensuring the strategy effectively addresses the distinct needs and regulatory landscapes of both the US and ROW markets.

The role works closely with sales, marketing, and other commercial teams to provide strategic medical input into product strategies, and to support both medical and marketing activities and market access. The individual is responsible for supporting the successful medical launch and product commercialization, always prioritizing patient care within the Chiesi Values and Behaviors framework.

 

Ideal candidate will be located in North Carolina to work a hybrid model out of our Cary, NC office. 

Main Responsibilities

• Drives the development and execution of the global medical strategy for Seralutinib in close partnership with the alliance partner and the ROW Medical Affairs Head.
• Incorporates insights from the ROW Medical Affairs Head to ensure the global strategy is comprehensive and reflective of ROW market perspectives.
• Aligns medical and scientific initiatives with Scientific Communication Platform and contributes to the development of and execution of the Medical Education, Advisory Boards and External Engagement Plan.
• Partners with the ROW Medical Head to co-create, integrate, and complement these initiatives with ROW efforts.
• Oversees the US Conference planning and execution.
• Map Patient Journeys for Seralutinib in the US, identifying key patient needs and apply the framework to the possible solutio